Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-24 @ 12:05 PM
NCT ID:
NCT00384761
Eligibility Criteria:
Inclusion Criteria:
* Ages 20-90+
* Normal performance status
* LDL cholesterol level \<120 mg/dl
* Fasting blood glucose \<99 mg/dL
* Blood pressure \<135 mmHg systolic and \<85 mmHg diastolic
* Non-smoker for at least 5 years
* BMI \>19 and \<26; stable body weight
* Free of neurological and psychological (Axis I) disorders for at least three years.
Exclusion Criteria:
* Age \<30
* Any oral antioxidants in the previous 2 weeks
* On lipid lowering medication in the past 8 weeks
* History of substance abuse
* Current cancer or history of cancer except basal cell cancer
* Any heart disease except for corrected congenital ht disease
* History of neurological disease
* History of chronic GI disorders
* History of inflammatory joint disorders
* Known endocrine disorders
* History of Chronic Pulmonary diseases e.g. COPD
* Acute illness such as infection in the previous 4 weeks
* Creatinine \> 2
* Liver enzymes \>1.5X normal
* Anemia (Hemoglobin \< 12.5) or chronic hematological disorder
* Physical limitation and sedentary status for any reason
* LDL cholesterol \> 120
* Fasting Glucose \> 99
* BP \>135/85 on 3 repeated measures
* Current smoker or smoker in the last 5 years
* History of depression
* Inability to give informed consent
For more information or patient referral call Johnson Pereira 404-275-0034, Rajinder Grover 404-686-7063, Muhammad Amer 404-805-4771 or Salman Sher 404-587-2667
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
90 Years
Study:
NCT00384761
Study Brief:
Protocol Section:
NCT00384761